SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-575196
Filing Date
2016-05-03
Accepted
2016-05-03 17:16:34
Documents
83
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d188156d10q.htm 10-Q 405741
2 EX-10.1 d188156dex101.htm EX-10.1 78969
3 EX-10.2 d188156dex102.htm EX-10.2 80866
4 EX-31.1 d188156dex311.htm EX-31.1 8338
5 EX-31.2 d188156dex312.htm EX-31.2 8412
6 EX-32.1 d188156dex321.htm EX-32.1 4893
  Complete submission text file 0001193125-16-575196.txt   3485372

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sgnt-20160331.xml EX-101.INS 533365
8 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20160331.xsd EX-101.SCH 45633
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20160331_cal.xml EX-101.CAL 81017
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20160331_def.xml EX-101.DEF 142395
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20160331_lab.xml EX-101.LAB 361087
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20160331_pre.xml EX-101.PRE 265240
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 161616452
SIC: 2834 Pharmaceutical Preparations